.jpg)
Every AI documentation demo has the same climactic moment: press the button, and the note appears. It is impressive, and it is also precisely the moment that should make a clinical director suspicious. If notes appear at the press of a button, where is the clinician's judgment in the workflow? Who is the author of this record?
That suspicion is correct, and it is the right evaluation lens. Unreviewed AI content in a clinical record is a liability, not a time saver. The useful question for any vendor is not whether AI can draft a note. Drafting is table stakes. The question is where, specifically, the clinician's thinking enters the workflow and where their approval gates the record. This post maps the three points where that should happen. It expands the safeguards section of our guide to AI in the EMR.
Control point one: instructions, before anything is drafted
The first place clinical judgment belongs is upstream of the AI entirely: in defining what a complete answer looks like.
Documentation standards are not generic. Your organization has positions on what a good response to each field requires: a client quote in the subjective section, specific measurements, content a particular payer expects to see. If the AI drafts against a generic template, it produces generic notes, and your standards live only in training sessions and audit findings.
The alternative is an instruction layer: field-by-field definitions of what a complete answer requires, authored by your clinical leadership, that the AI drafts against. This turns AI documentation from "what the model thinks a therapy note is" into "what your organization has decided this field requires." The clinical thinking happens once, deliberately, at the policy level, and then applies to every draft.
Vendor question: Can we define, per field and per payer, what the AI drafts against and checks documentation for? Or is there one template for everyone?
Control point two: review, before anything enters the record
The second control point is the obvious one, but the details matter more than the checkbox. Nearly every vendor will say a human reviews the output. The evaluation questions are sharper:
- Does AI output appear as a draft the clinician must accept, edit, or reject, or does it land in the record with review as an optional afterthought?
- Do drafting tools preserve the clinician's original meaning, or can they introduce content? The safe posture: no diagnoses added, no conclusions beyond what the clinician entered.
- Is the review step positioned inside the documentation workflow, or is it a separate queue that busy clinicians will learn to bulk-approve?
That last one is where good intentions fail. A review step that adds friction gets defeated by pace-of-work; twenty pending drafts at 6pm produces approve-all behavior. Review has to sit where the clinician already works, one note at a time, at the moment they would be finalizing anyway.
The principle underneath: the clinician remains the author of record. AI drafts. The clinician decides.
Vendor question: Show me the exact screen where a clinician reviews a draft. What can they change, and what stops an unreviewed draft from being signed?
Control point three: verification, before signature
The third control point is the one most evaluations miss, and it is arguably the most valuable: the same instruction layer that guides drafting can run in reverse, as a review that checks completed documentation against your requirements before signature.
This matters for two reasons. First, it works whether or not the note was drafted with AI. A clinician who types every word still benefits from a pre-signature check that flags a missing required element. Second, it changes the compliance posture from sampling to coverage: instead of a supervisor auditing five charts a month and extrapolating, every note can be checked against the standard before it is signed.
Drafting gets the demos. Verification is where documentation quality actually compounds, because it closes the loop on your standards regardless of who or what wrote the first draft.
Vendor question: Can the AI check notes against our field-level requirements without writing them? What does the clinician see when something is missing?
Reading a vendor through this map
Run any AI documentation product through the three control points and vendors separate quickly:
- Instructions: your standards, or a generic template?
- Review: a required gate the clinician works inside, or an optional layer that pace-of-work will erode?
- Verification: does the system check documentation against your requirements before signature, independent of drafting?
A vendor strong on all three has built AI around clinical judgment. A vendor who keeps steering back to the button has built a demo.
One more dimension belongs in every evaluation, and it deserves its own conversation: what happens to client data during AI processing, under what agreement, and what is retained. Ask it alongside everything above.
